Karen Adams
Corporate Secretary at OPTHEA LIMITED
Net worth: - $ as of 29/04/2024
Profile
Karen Adams is currently working as a Secretary & Vice President-Finance at Opthea Ltd., as a Secretary at Vegenics Pty Ltd., and as a Member at CPA Australia Ltd.
Previously, she worked as a Finance Director at Nexvet Australia Pty Ltd.
from 2014 to 2018, and as a Chief Financial Officer at Victor Smorgon Group from 2018 to 2021.
Ms. Adams completed her undergraduate degree at Swinburne University of Technology.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
OPTHEA LIMITED
-.--% | 27/09/2023 | 0 ( -.--% ) | - $ | 29/04/2024 |
Karen Adams active positions
Companies | Position | Start |
---|---|---|
OPTHEA LIMITED | Corporate Secretary | 14/06/2021 |
CPA Australia Ltd.
CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Corporate Officer/Principal | - |
Vegenics Pty Ltd.
Vegenics Pty Ltd. Medical/Nursing ServicesHealth Services Part of Opthea Ltd., Vegenics Pty Ltd. is an Australian company that provides medical research, development, and commercialization of biologic drugs. Vegenics was acquired by Opthea Ltd. on August 14, 2008 for $5.06 million. | Corporate Secretary | - |
Former positions of Karen Adams
Companies | Position | End |
---|---|---|
Victor Smorgon Group
Victor Smorgon Group Oil Refining/MarketingEnergy Minerals The Victor Smorgon Group is a private family office that focuses on building generational wealth. The private company is based in South Yarra, Australia. The Australian company has a long history of building wealth for over four generations, starting from humble beginnings. The company offers specialist investment services that provide unique and exciting investment opportunities to its extensive networks. The company was founded in 1995 by Peter Edwards, who has been the CEO since 1995. | Director of Finance/CFO | 30/04/2021 |
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Director of Finance/CFO | 31/07/2018 |
Training of Karen Adams
Swinburne University of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
OPTHEA LIMITED | Health Technology |
Private companies | 4 |
---|---|
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
Victor Smorgon Group
Victor Smorgon Group Oil Refining/MarketingEnergy Minerals The Victor Smorgon Group is a private family office that focuses on building generational wealth. The private company is based in South Yarra, Australia. The Australian company has a long history of building wealth for over four generations, starting from humble beginnings. The company offers specialist investment services that provide unique and exciting investment opportunities to its extensive networks. The company was founded in 1995 by Peter Edwards, who has been the CEO since 1995. | Energy Minerals |
CPA Australia Ltd.
CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Commercial Services |
Vegenics Pty Ltd.
Vegenics Pty Ltd. Medical/Nursing ServicesHealth Services Part of Opthea Ltd., Vegenics Pty Ltd. is an Australian company that provides medical research, development, and commercialization of biologic drugs. Vegenics was acquired by Opthea Ltd. on August 14, 2008 for $5.06 million. | Health Services |
- Stock Market
- Insiders
- Karen Adams